The invention refers to 9-nor-c21-pirazoirio C3, 3And the shape and composition of the crystals. This method also describes 19-nor-21-pyrazine-c3, 3-endosulfan-frumula (1) solid preparation and 1-norc21-pyrazine-c3, 3-endosulfan-solid preparation 19-nor-21, or solid crystal, acceptable pharmaceutical salts, And acceptable ingredients on drugs
展开▼